Notwithstanding a marginal increase in organ transplant rates over the past two years, Malaysia must undertake considerable ...

At the World Conference on Lung Cancer (WCLC ... that the companies recently took forward into phase 3. After a median follow-up of around 15 months, the overall response rate (ORR) with I ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half ...

Dermata Therapeutics shares jumped more than 50% in early trading Thursday after the biotechnology company said its Xyngari once-weekly, topical product candidate for the treatment of ...

This is the first report on the long-term durability of response among complete responders to mitomycin C chemoablation of low-grade upper tract urothelial carcinoma.

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

Lung cancer starts in your lungs and can spread to other parts of your body. There are more than 20 kinds of lung cancer. Some other conditions can have similar warning signs to lung cancer. It ...

3 PCACC is an extremely rare condition with no established consensus on the optimal workup, particularly in cases where histology reveals malignant features, as seen in our patient. Several case ...

If these natural techniques don't help, you may need over-the-counter or prescription expectorants. Clearing lung congestion eases symptoms and promotes healing from a cold, flu, or acute bronchitis.